Live OCD and Anxiety Lecture Series: Sessions III & IV - May 13, 2022

May 13, 2022

This presentation will be an ONLINE VIRTUAL LIVE on May 15, 2022, from 1:00 pm - 4:15 PM ET. While this activity is broadcast LIVE, the evaluation will be online until June 10, 2022 The link to attend the broadcast and download the slides will be emailed to registrants.

The views and opinions expressed by this presenter in this lecture are their own, and do not represent the views of Sheppard Pratt.

SESSION III: Tourettic OCD: A Conceptual Framework for Treating a Common OCD Subtype

There is substantial evidence for the etiological and phenomenological overlap between Obsessive-Compulsive Disorder and Tic Disorders. In 2005, the presenter formally introduced the term Tourettic OCD (TOCD) into the professional literature. The TOCD framework shares features with other formulations such as “tic-related OCD”, “just-right OCD”, “sensory-motor OCD” and with “complex tics”. Yet TOCD has unique characteristics and broader implications for understanding this cluster of clinical characteristics and for modifying standard CBT treatment to better serve this clinical subtype. This presentation aims to provide therapists with guidance for identifying such individuals, and with recommendations for providing them with effective treatment. The presenter will describe the conceptual model of “Tourettic OCD” as a coherent and valuable framework that guides clinical decision-making and effective treatment for these clients.

LEARNING OBJECTIVES

After this lecture, registrants will be able to:

  1. Describe similarities and differences in current conceptualizations and standard treatments for OCD and tic disorders.
  2. Describe the essential clinical characteristics of TOCD.
  3. Describe the kinds of modifications to standard OCD treatment warranted in cases of TOCD.

SESSION IV: Obsessive-Compulsive Disorder: Standard of Care and Innovative Treatment Strategies

Obsessive compulsive disorder is reasonably common, affecting about 1 person in 40 over the course of a lifetime, but often goes undiagnosed and inadequately treated.  This presentation will first provide an overview of the clinical presentation of OCD, with a focus on the complexity and heterogeneity that is often encountered.  We will then review well proven, standard-of-care treatments, with a brief overview of well-established cognitive-behavioral approaches and a more detailed discussion of standard pharmacotherapy.  Unfortunately, even optimal deployment of evidence-based treatments leaves about a third of patients with little meaningful improvement; many who do improve are left with troubling residual symptoms.  There is therefore an urgent need for new treatments for refractory disease.  The final portion of the talk will describe several novel treatment strategies being investigated in the speaker’s research group, including novel medications, new psychotherapies, and brain stimulation.

LEARNING OBJECTIVES

After this lecture, registrants will be able to:

  1. Recognize the core symptoms of OCD and differentiate them from frequently comorbid anxiety and mood symptomatology.
  2. Explain standard pharmacological strategies for the treatment of OCD.
  3. Discuss the use of glutamate-modulating drugs in the treatment of OCD that is refractory to first-and second-line treatment, recognizing that the evidence supporting these medications remains limited and better-proven treatments should always be tried first.

Target Audience

This activity is intended for physicians, nurses, psychologists, social workers, counselors, and other mental health professionals.

Course summary
Available credit: 
  • 3.00 ACEP NBCC clock hours
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Category I credits for Social Workers
  • 3.00 Psychologists
  • 3.00 MNA Contact Hours for Nurses
  • 3.00 Participation
Course opens: 
01/19/2022
Course expires: 
06/10/2022
Event starts: 
05/13/2022 - 1:00pm EDT
Event ends: 
05/13/2022 - 4:15pm EDT
Fee:
$75.00

SHEPPARD PRATT OCD & ANXIETY LECTURE SERIES

This series offers 9.0 contact hours.

This presentation will be an ONLINE VIRTUAL LIVE broadcast on May 13, 2022 from 1:00 PM - 4:15 PM ET. While this activity is broadcast LIVE, the evaluation will be online until June 10, 2022. The link to attend the broadcast and download the slides will be emailed to registrants.

Sessions I & II, Friday, April 15, 2022 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session I: How Good Do You Have to Be?: Exploring Moral Scrupulosity in OCD- Jon Hershfield, MFT

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session II: Shaping Motivation and Flexibility in OCD: Integrating ERP and Acceptance and Commitment Therapy - Lisa W. Coyne, PhD

Sessions III & IV, Friday, May 13, 2022, 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session III: Tourettic OCD: A Conceptual Framework for Treating a Common OCD Subtype- Charles S. Mansueto, PhD

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session IV: Obsessive-Compulsive Disorder: Standard of Care and Innovative Treatment Strategies- Christopher Pittenger, MD, PhD

Sessions V & VI, Friday, June 10, 2021, 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session V: Assessing and Treating Co-existing Eating Disorders and OCD - Kimberley Quinlan, LMFT

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session VI: Conceptualizing and Treating OCD in Autistic Individuals- Jonathan H. Hoffman, PhD, ABPP

In the event an announced speaker is unable to present, Sheppard Pratt reserves the right to present an alternative speaker on a comparable subject.

There is no commercial support for this activity.

About these speakers

Dr. Charles Mansueto is founder and director of the Behavior Therapy Center of Greater Washington. He received his doctorate from Catholic University and completed his post-doctoral clinical training at Temple University School of Medicine. He has over 35 years of experience in the application of behavior therapy to a broad range of clinical problems. Dr. Mansueto has written extensively and presented nationally and internationally on OCD and related disorders. He currently serves as a member of the Scientific and Clinical Advisory Board of the International Obsessive Compulsive Disorder Foundation and Chair of OCD Mid-Atlantic, an IOCDF affiliate. He also serves on the Scientific Advisory Board of the Trichotillomania Learning Center and the Medical Advisory Board of the Tourette Syndrome Association of Greater Washington. He retired as a tenured Professor of Psychology after 36 years in the University of Maryland System.

Christopher Pittenger, MD, PhD, is Mears & Jameson Professor of Psychiatry and Professor in the Child Study Center, Deputy Chair for Translational Research in Psychiatry, Director of the Yale OCD Research Clinic, and Director of the Neuroscience Research Training Program (NRTP) and the Clinical Neuroscience Research Unit at Yale University.  He completed his MD and PhD degrees at Columbia University and his residency in adult psychiatry at Yale.  His research focuses on the pathophysiology of obsessive-compulsive disorder (OCD), Tourette syndrome, and related conditions, and on harnessing new insights to develop novel strategies for diagnosis, prevention, and treatment; his work incorporates genetics, biochemistry, mechanistic studies in animal models, investigations of neuro-immune interactions, human neuroimaging and quantitative behavioral studies, psychotherapy and neurofeedback, testing novel pharmacological strategies in patients with refractory disease, and brain stimulation. 

His clinical expertise in the diagnosis and treatment of difficult cases of OCD is widely recognized; in 2017 he authored a comprehensive textbook on OCD with Oxford University Press.  He leads the scientific programming and grant selection committee at the International OCD Foundation (IOCDF) and sits on the Scientific, Clinical, and/or Educational Advisory Boards of the IOCDF, the PANDAS Network, the Neuroimmune Foundation, the UCSF and Mt. Sinai School of Medicine Physician-Training Programs, and the Stanford PANS Clinic.   As Director of the NRTP he leads Yale’s educational efforts for the training of physician-scientists in psychiatry and has mentored a generation of young investigators.  Dr. Pittenger’s work has been recognized and supported by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the International OCD Foundation, The Tourette’s Association of American, the Brain and Behavior Research Foundation, the Doris Duke Charitable Foundation, the Simons Foundation Autism Research Initiative, and numerous other charitable foundations and industry partners. 

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she (or a partner or spouse) has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Charles S. Mansueto, PhD reports that he has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months. He will not discuss any products, services, or off-label uses in this presentation.

Christopher Pittenger, MD, PhD, reports he will discuss off-label use for Riluzole, Memantine, Ketamine, and the investigational use of Tririluzole in this presentation. He also reports the following relationships with financial interest: Biohaven Pharmaceuticals - Consultant; Grant Support; Ceruvia Biosciences - Consultant.; Transcend Therapeutics - Grant Support; Freedom Biosciences - Consultant; Usona Institute - Grant Support.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana, Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.

This series offers 9.0 contact hours for attending all three dates.

Physician Statement: Sheppard Pratt is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity.  Sheppard Pratt designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Statement: Sheppard Pratt is an approved provider of continuing nursing education by Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity provides 3.0 contact hours for nurses.

Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity.  Sheppard Pratt designates this educational activity for a maximum of 3.0 contact hours for Psychologists.

Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity. This activity is approved for 3.0 contact hours in Category I credits for Social Workers.

Counselor Statement:  Sheppard Pratt has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098.  Programs that do not qualify for NBCC credit are clearly identified.  Sheppard Pratt is solely responsible for all aspects of the program.  This activity is available for 3.0 NBCC clock hours.

Available Credit

  • 3.00 ACEP NBCC clock hours
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Category I credits for Social Workers
  • 3.00 Psychologists
  • 3.00 MNA Contact Hours for Nurses
  • 3.00 Participation

Price

Fee:
$75.00
Please login or register to take this course.

This presentation will be an ONLINE VIRTUAL LIVE broadcast on May 13, 2022 from 1:00 PM - 4:15 PM ET. While this activity is broadcast LIVE, the evaluation will be online until June 10, 2022. The link to attend the broadcast and download the slides will be emailed to registrants.

Sessions I & II, Friday, April 15, 2022 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session I: How Good Do You Have to Be?: Exploring Moral Scrupulosity in OCD- Jon Hershfield, MFT

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session II: Shaping Motivation and Flexibility in OCD: Integrating ERP and Acceptance and Commitment Therapy - Lisa W. Coyne, PhD

Sessions III & IV, Friday, May 13, 2022, 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session III: Tourettic OCD: A Conceptual Framework for Treating a Common OCD Subtype- Charles S. Mansueto, PhD

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session IV: Obsessive-Compulsive Disorder: Standard of Care and Innovative Treatment Strategies- Christopher Pittenger, MD, PhD

Sessions V & VI, Friday, June 10, 2021, 1:00 pm – 4:15 pm, Online Broadcast

1:00 pm - Introduction of speaker by Jon Hershfield, MFT

1:00 pm – 2:30 pm  Session V: Assessing and Treating Co-existing Eating Disorders and OCD - Kimberley Quinlan, LMFT

2:30 pm – 2:45 pm  Break

2:45 pm  Introduction of speaker by Jon Hershfield, MFT

2:45 am – 4:15 pm  Session VI: Conceptualizing and Treating OCD in Autistic Individuals- Jonathan H. Hoffman, PhD, ABPP

In the event an announced speaker is unable to present, Sheppard Pratt reserves the right to present an alternative speaker on a comparable subject.

 

REGISTRATION FEES

General Registration: Activity fee to attend each activity $75.

Sheppard Pratt Registration: Activities are free to attend for all Sheppard Pratt Employees

 

REGISTER AND MAKE PAYMENT

Payment can be made by credit card online through the Sheppard Pratt Ethos System. We accept Visa, MasterCard, American Express and Discover.

To register to earn credit for attending this activity, log into or register for an account in Sheppard Pratt’s Ethos continuing education system at https://cme.sheppardpratt.org/

Select the activity by double clicking on the title and select add to cart.

Follow the prompts until the payment and registration process is complete.

 

WITHDRAWAL DEADLINES & REFUND POLICY

April 15th: Friday, April 1, 2022, is the deadline to request a refund for withdrawal from the April 15, 2022, event.

May 13th:  Friday, April 29, 2022, is the deadline to request a refund for withdrawal from the May 13, 2022, event.

June 10th: Friday, May 27, 2022, is the deadline to request a refund for withdrawal from the June 10, 2022, event.

 

Refunds are subject to a $20 administrative charge.

No refunds or credits will be issued for withdrawal after the listed deadlines. All purchases are non-transferable. 

 

WATCH THE BROADCAST AND PRINT THE HANDOUT

An email with the link to view the broadcast and handout attachments will be sent to registrants on September 16, 2021.

 

EARN CONTINUING EDUCATION CREDIT FOR YOUR ATTENDANCE

PRIOR TO THE EVENT: Log into your Sheppard Pratt Ethos account and register by taking the pretest. Select the activity by series, title or speaker name. Go to the last tab, REGISTER and select the GREEN RECTANGLE, TAKE COURSE, and follow the prompts. Complete the Pretest and select attendance and you will be registered for this activity. You will not be able to work further until you are marked attended by an administrator.

DURING THE EVENT: Because you will view this event online, there will not be a sign in sheet. Instead of signing in, a code word will be given during the lecture for you. There are two ways to enter the code word: by text/SMS & through the website. To use the website to enter the code word to be marked attended, you will go to https://cme.sheppardpratt.org/code and enter the code word there. To use SMS to enter the code word, you will text the code word to 410-291-8061. To save time, add this phone number to your contacts. You will have one week from the workshop date to enter the code word. Once you enter the code word, you can click on My Account > Pending Activities and you will see the course listed there. From this tab you will be able to complete your course.

AFTER THE LECTURE: Select the activity by series, title or speaker name. Select the last tab, TAKE COURSE, and select the GREEN RECTANGLE, TAKE COURSE and follow the prompts. Please use the navigation button located in the lower right corner to continue throughout the course for best results. Complete the evaluation and credit designation to earn continuing education hours or credits. Your transcript will reflect all completed events.

Questions? Look at our FAQ’s at https://cme.sheppardpratt.org/content/faq or Email cme@sheppardpratt.org

Required Hardware/software

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+

Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+

Operating System: Windows XP+ or Mac OS X 10.4+

Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera

Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.